Leukemia, Plasma Cell - 22 Studies Found Terminated : Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen : Multiple Myeloma Plasma Cell Leukemia : 2008-01-22 : Drug: Fludarabine/Busulfan x 4 days Not yet recruiting : Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma : Plasma Cell Leukemia in Remission Plasma Cell Myeloma : 2017-03-29 : Procedure: Autologous Hematopoietic Stem Cell Transplantation Recruiting : SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy : Partial Response of Multiple Myeloma or Plasma Cell Leukemia Pl : 2015-01-06 : Biological: Incomplete Freund's Adjuvant Recruiting : Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) : Multiple Myeloma Multiple Myeloma in Relapse Mantle Cell L : 2011-09-14 : Biological: SNS01-T 0.05 mg/kg Completed : Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia : Multiple Myeloma and Plasma Cell Neoplasm : 2005-11-22 : Dietary Supplement: ascorbic acid Recruiting : Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia : B-Cell Prolymphocytic Leukemia Hypodiploidy Loss of Chromo : 2009-11-04 : Procedure: Allogeneic Bone Marrow Transplantation Not yet recruiting : Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases : Acute Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL) Drug: Fludarabine 25 mg/m^2 IV Recruiting : Allo HSCT Using RIC for Hematological Diseases : Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Chro : 2016-01-19 : Drug: Allopurinol 300 mg/day ( Recruiting : UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep : Acute Leukemia Acute Myeloid Leukemia Acute Lymphoblastic : 2016-03-24 : Drug: Fludarabine Both Arms: 3 Recruiting : Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies : Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia S : 2015-09-21 : Drug: Fludarabine Days -6 thro <<< Previous | Next >>>